Myeloid Metaplasia
6 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| A Phase 1 Dose Escalation Study of TAK-901 in Subjects With Advanced Hematologic Malignancies (NCT00807677) | Millennium Pharmaceuticals, Inc. | 2009-03-01 |
| A Phase II Study of Pomalidomide in Myelofibrosis With Myeloid Metaplasia (NCT00463385) | Celgene | 2007-04-01 |
| A Trial of Zoledronic Acid in Patients With Myelofibrosis With Myeloid Metaplasia (MMM) (NCT00287261) | Universitaire Ziekenhuizen KU Leuven | 2006-02-01 |
| Study of AP23573 in Patients With Relapsed or Refractory Hematologic Malignancies (8669-024)(COMPLETED) (NCT00086125) | Merck Sharp & Dohme LLC | 2004-06-01 |
| A Study of Gleevec in Patients With Idiopathic Myelofibrosis or Chronic Myelomonocytic Leukemia (CMML) (NCT00136409) | Dana-Farber Cancer Institute | 2002-05-01 |
Track Myeloid Metaplasia automatically
Every clearance here is in the API, with alerts when new ones post.